Featured Industry Event Listing
Featured
VASCEPA® (icosapent ethyl)—Elevating the Standard of Care
A Collaborative Discussion to Better Understand and Expedite the Patient Journey
Developed and offered by someone
Another line
We won't add links - this is only a test
H2
- HTML possible
- in excerpt
What’s New with GLP-1?
All sessions will be released on their scheduled date and time. The meeting is scheduled in U.S. Central Time. Registered attendees will receive unlimited access to all virtual content for […]
Transitions in Diabetes
All sessions will be released on their scheduled date and time. The meeting is scheduled in U.S. Central Time. Registered attendees will receive unlimited access to all virtual content for […]
Patients with Low Estimated Glomerular Filtration Rate
GEORGE BAKRIS, Chicago, IL
Immunity, Metabolism, and Diabetes
All sessions will be released on their scheduled date and time. The meeting is scheduled in U.S. Central Time. Registered attendees will receive unlimited access to all virtual content for […]
VASCEPA® (icosapent ethyl)—Elevating the Standard of Care (This Product Theater is Presented Live)
There is an urgency to treat Persistent Cardiovascular Risk (P-CVR) as it remains high despite statin-based standard-of-care therapy in patients with elevated triglycerides. In this program, we will review data […]
Population Health Efforts in the Prevention and Treatment of Diabetes
All sessions will be released on their scheduled date and time. The meeting is scheduled in U.S. Central Time. Registered attendees will receive unlimited access to all virtual content for […]
Weekly Basal Insulin—The Wave of the Future?
All sessions will be released on their scheduled date and time. The meeting is scheduled in U.S. Central Time. Registered attendees will receive unlimited access to all virtual content for […]